Research & Development
Sysmex has a variety of technology platforms, such as for genes, cells and proteins, and is pushing forward with technological developments aimed at contributing to personalized medicine, thereby creating new clinical value.
We are working on technologies to enable the measurement of gene quantities inside cancer cells and the detection of circulating cancer cell-derived DNA.
We are working on technologies to allow the specific detection of nucleic acid, organelles and other elements within cells, as well as the detection of in-cell protein locations and chromosomal aberrations.
We are working on technologies to detect proteins in blood and urine at high speeds and with a high degree of precision, and further enhancing testing parameters.
Through its efforts in leading-edge technologies, Sysmex is working to create testing and diagnostic technologies of unprecedented value.